Patent details

Basic Information

Publication number:

EP2873674

PCT Application Number:

JP2013069107

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138167911

PCT Publication Number:

WO2014010718

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CHIRAL NUCLEIC ACID ADJUVANT

French Title of Invention:

ADJUVANT D'ACIDE NUCLÉIQUE CHIRAL

German Title of Invention:

ADJUVANS FÜR CHIRALE NUKLEINSÄURE

SPC Number:

Dates

Filing date:

12/07/2013

Grant date:

06/05/2020

EP Publication Date:

20/05/2015

PCT Publication Date:

16/01/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/05/2020

EP B1 Publication Date:

06/05/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/07/2020

Expiration date:

12/07/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/04/2020

 

 

Name:

Shin Nippon Biomedical Laboratories, Ltd.

Address:

2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394, Japan (JP)

Name:

WaVe Life Sciences Japan, Inc.

Address:

2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394, Japan (JP)

Inventor

Name:

GEMBA, Takefumi

Address:

Japan (JP)

Priority

Priority Number:

201261671654 P

Priority Date:

13/07/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 39/39; A61P 11/00; A61P 17/02; A61P 31/00; A61P 35/00; A61P 37/00; A61P 43/00; C07H 21/04; C12N 15/00; C12N 15/117;

Publication

European Patent Bulletin

Issue number:

202019

Publication date:

06/05/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages